Literature DB >> 3288560

Pharmacologic manipulation of the ductus arteriosus in the neonate: a physiologic basis and current state of the art.

S K Sanyal, A Abu-Melha.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 3288560     DOI: 10.1007/bf02722558

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  43 in total

1.  Premature narrowing or closure of the foramen ovale.

Authors:  M LEV; R ARCILLA; H J RIMOLDI; R H LICATA; B M GASUL
Journal:  Am Heart J       Date:  1963-05       Impact factor: 4.749

2.  Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2.

Authors:  F Coceani; P M Olley; E Bodach
Journal:  Prostaglandins       Date:  1975-02

3.  An Anatomical Study of the Closure of the Ductus Arteriosus.

Authors:  B V Jager; O J Wollenman
Journal:  Am J Pathol       Date:  1942-07       Impact factor: 4.307

4.  Congestive heart failure from suspected ductal closure in utero.

Authors:  R A Arcilla; O G Thilenius; K Ranniger
Journal:  J Pediatr       Date:  1969-07       Impact factor: 4.406

5.  Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.

Authors:  K Ueda; A Saito; H Nakano; M Aoshima; M Yokota; R Muraoka; T Iwaya
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

6.  Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities.

Authors:  M A Heymann; W Berman; A M Rudolph; V Whitman
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

7.  Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus--a double-blind controlled study.

Authors:  T F Yeh; J A Luken; A Thalji; D Raval; I Carr; R S Pildes
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

8.  Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

Authors:  W M Gersony; G J Peckham; R C Ellison; O S Miettinen; A S Nadas
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

9.  Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.

Authors:  J M Neutze; M B Starling; R B Elliott; B G Barratt-Boyes
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

10.  Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.

Authors:  A C Gittenberger-de Groot; A J Moulaert; E Harinck; A E Becker
Journal:  Br Heart J       Date:  1978-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.